{{Rsnum
|rsid=4362
|Gene=ACE
|Chromosome=17
|position=63496400
|Orientation=plus
|GMAF=0.4408
|Gene_s=ACE
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 25.7 | 47.8 | 26.5
| HCB | 45.3 | 43.8 | 10.9
| JPT | 24.8 | 55.8 | 19.5
| YRI | 33.3 | 45.6 | 21.1
| ASW | 40.4 | 42.1 | 17.5
| CHB | 45.3 | 43.8 | 10.9
| CHD | 33.0 | 51.4 | 15.6
| GIH | 37.6 | 47.5 | 14.9
| LWK | 40.0 | 48.2 | 11.8
| MEX | 41.4 | 39.7 | 19.0
| MKK | 23.1 | 51.9 | 25.0
| TSI | 13.7 | 46.1 | 40.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=24622918
|Title=Renin-Angiotensin System Genetic Polymorphisms and Brain White Matter Lesions in Older Australians
}}{{PMID Auto
|PMID=18057531
|Title=Homogeneous assay of rs4343, an ACE I/D proxy, and an analysis in the British Women's Heart and Health Study (BWHHS).
|OA=1
}}

{{PMID Auto
|PMID=18076107
|Title=Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.
|OA=1
}}

{{PMID Auto
|PMID=19105203
|Title=An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.
|OA=1
}}

{{PMID Auto
|PMID=19132786
|Title=Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians.
}}

{{PMID Auto
|PMID=20416077
|Title=Identification of type 2 diabetes-associated combination of SNPs using support vector machine.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}